(Q35888698)

10 August 2017

1 reference

title

Immunotherapy for Epstein-Barr virus-associated tumors (English)

1 reference

10 August 2017

0 references

1 reference

Melanie A Comito

1

1 reference

10 August 2017

Qi Sun

series ordinal

2

1 reference

10 August 2017

Kenneth G Lucas

series ordinal

3

1 reference

10 August 2017

publication date

1 October 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

45

1 reference

10 August 2017

issue

10

1 reference

10 August 2017

page(s)

1981-1987

1 reference

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Epstein-Barr virus infections in children after transplantation of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Biology and management of AIDS-associated primary CNS lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Immunotherapy for post-transplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001700831

10.1080/10428190410001700831

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference